Old Web
English
Sign In
Acemap
>
authorDetail
>
Mandy Fräßdorf
Mandy Fräßdorf
Boehringer Ingelheim
Cardiology
Atrial fibrillation
Dabigatran
Internal medicine
Warfarin
2
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial.
2020
European Heart Journal
Michael Böhm
Martina Brueckmann
John W. Eikelboom
Michael D. Ezekowitz
Mandy Fräßdorf
Ziad Hijazi
Stefan H. Hohnloser
Felix Mahfoud
Roland E. Schmieder
Helmut Schumacher
Lars Wallentin
Salim Yusuf
Show All
Source
Cite
Save
Citations (10)
Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial
2019
Europace
Aiman Alak
Stefan H. Hohnloser
Mandy Fräßdorf
Paul A. Reilly
Michael D. Ezekowitz
Jeff S. Healey
Martina Brueckmann
Salim Yusuf
Stuart J. Connolly
Show All
Source
Cite
Save
Citations (3)
1